Loading organizations...
Loading organizations...
Develops T cell receptor mimics for cancer treatment.
Ypsilon has raised $2.7M across 1 funding round.
Ypsilon has raised $2.7M in total across 1 funding round.
Ypsilon has raised $2.7M in total across 1 funding round.
Ypsilon has raised $2.7M across 1 funding round. Most recently, it raised $2.7M Seed in January 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 30, 2025 | $2.7M Seed |